Thursday 4 July 2019

Researchers engineered a strain of non-pathogenic bacteria that colonize solid tumors and safely deliver immunotherapies, acting as a Trojan horse. The therapy led not only to complete tumor regression in a mouse model of lymphoma, but also significant control of distant, uninjected tumor lesions.

Researchers engineered a strain of non-pathogenic bacteria that colonize solid tumors and safely deliver immunotherapies, acting as a Trojan horse. The therapy led not only to complete tumor regression in a mouse model of lymphoma, but also significant control of distant, uninjected tumor lesions. submitted by /u/mvea
[link] [comments]


from Health https://ift.tt/2Yuyca8
via IFTTT

No comments:

Post a Comment